TY - JOUR
T1 - Mortality of bullous pemphigoid
T2 - An evaluation of 223 patients and comparison with the mortality in the general population in the United States
AU - Parker, Sareeta R.S.
AU - Dyson, Senait
AU - Brisman, Stacey
AU - Pennie, Michelle
AU - Swerlick, Robert A.
AU - Khan, Rizwana
AU - Manos, Sue
AU - Korman, Benjamin D.
AU - Xia, Zongqi
AU - Korman, Neil J.
PY - 2008/10
Y1 - 2008/10
N2 - Background: There are large discrepancies in reported mortality for bullous pemphigoid (BP). Objective: We sought to determine the mortality of a large cohort of patients with BP and compare this with age-matched control subjects. Methods: Data were collected on 223 patients with a new diagnosis of BP between 1998 and 2003 through our cutaneous immunofluorescence laboratory databases. The mortality of patients with BP was compared with that of age-matched control subjects in the general US population. Results: The 1-, 2-, and 5-year mortality was 0.23 (95% confidence interval = 0.18, 0.29), 0.37 (95% confidence interval = 0.31, 0.44), and 0.50 (95% confidence interval = 0.42, 0.57), respectively. However, relative to age-matched control subjects, no difference in expected mortality was detected. Limitations: This was a retrospective cohort analysis. Conclusions: Mortality of patients with BP is more likely related to advanced age and associated medical conditions than to disease-specific factors.
AB - Background: There are large discrepancies in reported mortality for bullous pemphigoid (BP). Objective: We sought to determine the mortality of a large cohort of patients with BP and compare this with age-matched control subjects. Methods: Data were collected on 223 patients with a new diagnosis of BP between 1998 and 2003 through our cutaneous immunofluorescence laboratory databases. The mortality of patients with BP was compared with that of age-matched control subjects in the general US population. Results: The 1-, 2-, and 5-year mortality was 0.23 (95% confidence interval = 0.18, 0.29), 0.37 (95% confidence interval = 0.31, 0.44), and 0.50 (95% confidence interval = 0.42, 0.57), respectively. However, relative to age-matched control subjects, no difference in expected mortality was detected. Limitations: This was a retrospective cohort analysis. Conclusions: Mortality of patients with BP is more likely related to advanced age and associated medical conditions than to disease-specific factors.
UR - http://www.scopus.com/inward/record.url?scp=51349106166&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=51349106166&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2008.07.022
DO - 10.1016/j.jaad.2008.07.022
M3 - Article
C2 - 18707800
AN - SCOPUS:51349106166
SN - 0190-9622
VL - 59
SP - 582
EP - 588
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 4
ER -